Allen Ho, MD
Real-world data analysis confirms that the use of ForeseeHome provides a significant benefit to patients as a means of increasing the early detection of wet AMD. Earlier detection of wet AMD with this FDA cleared device is a strong predictor of better vision over time with current anti-VEGF therapy.
Jeffrey Heier, MD
Artificial intelligence enabled home monitoring between office visits could be extremely helpful in early detection of conversion and the ForeseeHome program is a meaningful complement to the at-risk intermediate dry AMD patient’s care plan.
T. Mark Johnson, MD, FRSCS
The ability of ForeseeHome to detect very early conversion to wet AMD is of paramount importance to patients to ensure better visual outcomes.
Susan’s ForeseeHome Story with Byron Ladd, MD
Susan and her physician, Byron Ladd, MD, discuss the ForeseeHome AMD Monitoring Program
Eloine’s ForeseeHome Story with Jeffrey Heier, MD
Eloine’s ForeseeHome Story with Jeffrey Heier, MD
Mark Dunbar, OD
"ForeseeHome has empowered me to provide the best possible opportunity and solution to my patients to self-monitor their disease... It gives me the confidence that I am doing everything at my disposal to monitor and detect change as early as possible."
Jeffry Gerson, OD, FAAO
"ForeseeHome has helped me be more confident in following patients who are at higher risk for conversion to wet AMD... and gives my practice a technology advantage, which helps us stand out."
Jessica Haynes, OD, FAAO
"When you tell patients about a new home monitoring device, they see their doctor as up-to date on the latest technology. These patients are more likely to remain in your practice and to tell their friends about their experience in your clinic."
Damon Dierker, OD, FAAO
"Retina specialists are always pleased when I send a patient with 20/20 or 20/25 wet AMD because the patient will need fewer injections and almost always does really well."
S. Barry Eiden, OD, FAAO, FSLS
"ForeseeHome has become an integral component of our comprehensive approach to the management of intermediate AMD."
Rhonda Ullom, COMT, OSC, FCLSA, OCS, OSCR
"This is a great monitoring program for patients at risk of change from intermediate dry to wet AMD. We have several patients using the ForeseeHome device between office visits to detect conversion early. The remote monitoring center we refer our patients to has a user-friendly e-prescription workflow. When you can offer your patients peace of mind, why wouldn’t you?"
Eric’s ForeseeHome Story
Eric discusses how the ForeseeHome AMD Monitoring Program gives him peace of mind by monitoring for conversion in-between office visits
Susan’s ForeseeHome Experience with Byron Ladd, MD
Susan and her physician, Byron Ladd, MD, discuss the ForeseeHome AMD Monitoring Program
